Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.4 USD | -4.51% | -7.45% | -43.29% |
04-25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
04-25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.29% | 781M | |
+3.97% | 106B | |
+7.02% | 23.47B | |
-14.69% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-10.27% | 16.78B | |
+5.68% | 14.41B | |
+35.25% | 12.86B | |
+323.15% | 8.78B |
- Stock Market
- Equities
- SAGE Stock
- News Sage Therapeutics, Inc.
- Transcript : Sage Therapeutics, Inc. - Special Call